Ad is loading...
MENU

ESPR Esperion Therapeutics Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products

ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ESPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ESPR is expected to report earnings to fall 6.53% to -14 cents per share on February 27

Esperion Therapeutics ESPR Stock Earnings Reports
Q4'24
Est.
$-0.14
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.17
Q1'24
Beat
by $0.29
Q4'23
Missed
by $0.03
The last earnings report on November 07 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 5.57M shares outstanding, the current market capitalization sits at 495.94M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSFJX14.05N/A
N/A
Natixis Target Retirement 2045 N
MMSIX12.96-0.02
-0.15%
Praxis Small Cap Index I
BGRUX111.03-0.51
-0.46%
Baron Growth R6
PMJAX11.51-0.06
-0.52%
PIMCO RAE US Small A
WFSAX33.43-0.24
-0.71%
Allspring Small Company Growth A

ESPR and Stocks

Correlation & Price change

A.I.dvisor tells us that ESPR and PTPI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESPR and PTPI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESPR
1D Price
Change %
ESPR100%
+10.06%
PTPI - ESPR
29%
Poorly correlated
+7.76%
CTLT - ESPR
28%
Poorly correlated
+0.87%
ZOM - ESPR
26%
Poorly correlated
+0.87%
EVO - ESPR
26%
Poorly correlated
+1.95%
ORGO - ESPR
26%
Poorly correlated
-4.89%
More